Reader sentiment, not investment advice. One vote per visitor; click again to change it.
PBH is priced at $45.60 right now, up 0.75% on the session. That puts its market value at $2.16B, 2718th largest among the 3132 stocks we cover.
It is close to the bottom of its 52-week range ($42.62 to $71.07), 35.8% under the high.
Valuation works out to 12.8 times trailing earnings, 167% above its five-year average of 4.8.
2 analysts follow the stock and the average call is "buy". The mean target, $72.00, sits 57.9% over where the stock trades.
This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.
Composite of 3 factors below, ranked against the 3132 U.S. stocks BeStock covers.
Cheaper than usual on its own 5-year P/E history scores higher.
Trading closer to its 52-week high than most peers scores higher.
2 analysts, consensus Buy.
How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.
PBH is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.
Since 2021-01-04, the strategy has returned 389% (231.1% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated weekly — not a guarantee of future results, and not a BeStock recommendation.
What Wall Street analysts and Morningstar's fair-value model expect for the stock
Wall Street’s average 12-month target is $72.00, 57.9% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $70.00, so shares trade 34.9% below that estimate. On earnings multiple, it sits in the 26th percentile of its own five-year valuation range (cheaper than usual).
Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.
Quote as of Oct 5, 2026 10:20 pm ET. Prices can lag the live tape. This is background information, not a recommendation.
Ranks are among the 3,132 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.
$45.60 is the latest print for PBH, a move of +0.75% against yesterday's close of $45.26. Today's low and high so far: $44.77 and $45.88.
Equity value comes to $2.16B at the current price. By that measure it is number 2718 of the 3132 names in our coverage.
Buyers pay 12.8 times the last twelve months of profit (EPS $3.91). Averaged over five years the multiple has been 4.8, and today's level ranks in the 26th percentile of its own history.
The year's floor is $42.62 and the ceiling $71.07. Shares are 35.8% away from that ceiling.
Our data shows no dividend paid by Prestige Consumer Healthcare over the trailing twelve months.
Of 2 analysts, 100% say buy, 0% hold and 0% sell. Price targets average $72.00, with the most cautious at $72.00 and the most optimistic at $72.00.
BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.
No comments yet — be the first to weigh in on PBH.